SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -62.5% | 11,235 | -43.1% | 0.00% | – |
| Q1 2020 | $8,000 | -74.2% | 19,735 | -78.2% | 0.00% | – |
| Q4 2019 | $31,000 | +138.5% | 90,735 | +386.9% | 0.00% | – |
| Q3 2019 | $13,000 | -27.8% | 18,635 | -24.0% | 0.00% | – |
| Q2 2019 | $18,000 | -10.0% | 24,535 | +51.1% | 0.00% | – |
| Q1 2019 | $20,000 | +185.7% | 16,235 | -4.1% | 0.00% | – |
| Q4 2018 | $7,000 | -82.5% | 16,935 | -15.6% | 0.00% | – |
| Q3 2018 | $40,000 | -2.4% | 20,069 | +3.1% | 0.00% | – |
| Q2 2018 | $41,000 | – | 19,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,134,926 | $3,375,000 | 3.69% |
| Aisling Capital Management LP | 10,100,000 | $4,190,000 | 1.82% |
| Samsara BioCapital, LLC | 5,938,215 | $2,464,000 | 1.42% |
| Corriente Advisors, LLC | 3,021,692 | $1,254,000 | 1.35% |
| MPM BioImpact LLC | 2,809,912 | $1,166,000 | 0.71% |
| Burrage Capital Management LLC | 682,586 | $280,000 | 0.28% |
| Avidity Partners Management LP | 4,310,000 | $1,788,000 | 0.25% |
| BVF INC/IL | 6,194,925 | $2,570,000 | 0.24% |
| Nantahala Capital Management | 9,566,844 | $3,969,000 | 0.15% |
| Worth Venture Partners, LLC | 362,330 | $150,000 | 0.09% |